FDA Device Intelligence
Home › Advalight ApS › ADVATx

ADVATx

Advalight ApS · Model 1.0 · UDI-DI 05700002052209

GEX
1
510(k) clearances
44,260
Adverse events (107 deaths)
201
Recalls
489
Facilities

Description

The laser system is for dermatological indications for use. The laser light is delivered to the patient through an applicator either a scanning hand piece or a single spot hand piece (optional). The ADVATx Laser System consists of a laser cabinet which houses the laser module, the user interface which allows the user to control the system and the laser delivery system. ADVATx does only come in one model. The laser does not use any consumables (besides standard power/electricity), and no accessories are offered. The ADVATx laser system is a Nd:YAG laser delivering 589nm Q-switched pulsed light and 1319nm continuous wave light. This laser has been developed specifically for dermatological (skin) treatments performed by healthcare professionals e.g. doctors.

Recalls

DateFirmReason
2026-08-06Lutronic CorporationUtilizing higher fluences at 1064nm wavelength with current cryogen parameters may result in a spark/loud noise during treatment, potentially resulting in patient burn.
2026-05-05IPG Medical CorporationSoftware anomaly that causes a false display of error code 5018.
2026-02-27Olympus Corporation of the AmericasFollowing a complaint investigation, Olympus identified a potential defect in the 24V power supply module in some SOLTIVE laser units which may cause the system to become inoperabl
2026-02-27Olympus Corporation of the AmericasFollowing a complaint investigation, Olympus identified a potential defect in the 24V power supply module in some SOLTIVE laser units which may cause the system to become inoperabl
2026-01-27Lutronic CorporationReports of devices sparking/popping and potentially burning patients.
2025-12-15LEASEIR TECHNOLOGIES SLUThe console label for affected devices is missing the "DANGER" symbol.
2025-07-22LUMENIS, LTD.The potential for unsterilized product within finished product labeled as sterile.
2025-05-06Olympus Corporation of the AmericasPotential for thermal incident including an unexpected occurrence of smoke, sparks, burning, or unsteady flames during clinical use. The fracturing of the fiber is the cause of, or
2025-05-06Olympus Corporation of the AmericasPotential for thermal incident including an unexpected occurrence of smoke, sparks, burning, or unsteady flames during clinical use. The fracturing of the fiber is the cause of, or
2025-05-06Olympus Corporation of the AmericasPotential for thermal incident including an unexpected occurrence of smoke, sparks, burning, or unsteady flames during clinical use. The fracturing of the fiber is the cause of, or

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.